Mode
Text Size
Log in / Sign up

Rhythm control for postcardiac surgery atrial fibrillation shows higher conversion rates but increased risksRhythm Control Shows Higher Risks for Post-Surgery Heart Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that aggressive rhythm control increases sinus rhythm conversion odds but also elevates risks of medication side effects.

The study evaluated the clinical impact of various rhythm control interventions, including ibutilide, procainamide, and propafenone, compared to rate control strategies in patients with new onset atrial fibrillation following cardiac surgery. The primary focus was determining if aggressive rhythm management provided superior outcomes over standard rate control.

The findings indicated that while an aggressive rhythm control strategy led to higher odds of conversion to sinus rhythm within the hospital, it did not result in a significant difference in the length of hospital stay compared to rate control. However, patients receiving the more intensive rhythm control interventions experienced a higher risk of medication related adverse events, specifically including hypotension, bradycardia, and syncope.

The authors noted that there is currently no evidence suggesting that a rhythm control strategy provides superior clinical outcomes over a rate control strategy for these specific patients. Clinicians should weigh the potential for faster sinus rhythm conversion against the increased risk of adverse drug effects when managing postoperative atrial fibrillation.

Researchers looked at how different treatment methods affect patients who develop atrial fibrillation after heart surgery. They compared a strategy called rhythm control, which uses medications like ibutilide or propafenone, against a standard rate control approach. The study included nearly 900 patients across several clinical trials.

The results showed that while the more aggressive rhythm control method led to higher odds of converting back to a normal heart rhythm, it also came with significant risks. Specifically, patients receiving these medications had a much higher risk of experiencing side effects such as low blood pressure, slow heart rates, and fainting.

Importantly, the study found no difference in how long patients stayed in the hospital between the two treatment methods. Because of the increased risk of medication-related issues, there is currently no evidence that rhythm control provides better overall outcomes for these specific patients compared to standard rate control.

What this means for you:
Rhythm control may increase heart side effects without shortening hospital stays for post-surgery atrial fibrillation.

Common questions

What are the risks of using aggressive rhythm control medications?

Patients receiving aggressive rhythm control strategies had a significantly higher risk of medication-related adverse events. These specific issues included hypotension (low blood pressure), bradycardia (slow heart rate), and syncope (fainting). The study showed these risks were notably higher compared to standard rate control treatments.

Does rhythm control help patients stay in the hospital for less time?

The study found no difference in the length of hospital stays between those who received rhythm control and those who received rate control. While the aggressive treatment had a higher chance of converting to a normal heart rhythm, it did not result in shorter hospital stays for these patients.

Who is affected by these findings?

These results specifically concern patients who develop new-onset atrial fibrillation after undergoing cardiac surgery. Because the evidence shows no better outcomes for these patients with rhythm control despite higher risks of side effects, you should discuss these specific treatment options and risks with your doctor.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
We aimed to compare the clinical impact of treatment with a rhythm control strategy to a rate control strategy in postcardiac surgery atrial fibrillation patients. A comprehensive search of MEDLINE, Embase, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, Scopus, ProQuest Dissertations, and ClinicalTrials.gov was conducted from inception to October 2025. Our meta-analysis included randomized controlled trials (RCTs) comparing therapeutic rhythm control interventions with rate control interventions. We used the Cochrane risk-of-bias tool to appraise the quality of included RCTs, the GRADE framework to evaluate the strength of the evidence, and adhered to the PRISMA guidelines for reporting. Eight RCTs (n = 894 patients) met the inclusion criteria. There was no difference in hospital length of stay (4 RCTs) between rhythm control and rate control [MD: −0.41 days (95% CI: −3.23, 2.42)]. An aggressive rhythm control strategy (ibutilide, procainamide, propafenone, or electric cardioversion) was associated with higher odds of in-hospital conversion to sinus rhythm [OR: 4.01 (95% CI: 1.30, 12.39)] and a higher risk of medication-related adverse events (hypotension, bradycardia, and syncope) [RR: 3.05 (95% CI: 1.05, 8.89)]. Among postcardiac surgery patients with new-onset atrial fibrillation, there was no evidence that a rhythm control treatment strategy resulted in better outcomes than a rate control strategy. https://www.crd.york.ac.uk/PROSPERO/view/CRD42019128559, identifier CRD42019128559.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.